marketing authorization

A Note to Our Customers Regarding the FDA

February 19, 2015
By Anne Wojcicki Today, 23andMe was granted authorization by the U.S. Food and Drug Administration (FDA) to market the Bloom syndrome carrier status report. This is an important first step...
Read More